All-trans retinoic acid is reported to inhibit acute promyelocytic leukemia and breast cancer27 via ablation of Pin1, but toxicity8–11 and drug resistance28,29 of the molecule limit its application in human patients. Here, PIN1 is linked to acute promyelocytic leukemia.